Imatinib-supplemented myeloablative total-body irradiation/cyclophosphamide conditioning prior to allogeneic stem cell transplantation as consolidation treatment in patients with blast crisis of chronic myeloid leukemia

Eur J Haematol. 2014 Jun;92(6):546-9. doi: 10.1111/ejh.12289. Epub 2014 Mar 15.

Authors

Aleksandar Radujkovic¹, Peter Dreger, Ute Hegenbart, Eike C Buss, Thomas Luft, Anthony D Ho, Stefan Fruehauf, Julian Topaly

Affiliation

¹ Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.

PMID: 24527710
DOI: 10.1111/ejh.12289

No abstract available

Publication types

Letter

MeSH terms

Benzamides / administration & dosage
Cyclophosphamide / administration & dosage
Hematopoietic Stem Cell Transplantation*
Humans
Imatinib Mesylate
Leukemia, Myeloid, Chronic-Phase / therapy*
Piperazines / administration & dosage
Pyrimidines / administration & dosage
Transplantation Conditioning*
Transplantation, Homologous
Treatment Outcome
Whole-Body Irradiation*

Substances

Benzamides
Piperazines
Pyrimidines
Imatinib Mesylate
Cyclophosphamide